CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2011	Dec. 31, 2010
Current Assets
Cash and cash equivalents	$ 140,364	$ 23,217
Prepaid expenses	24,682	12,697
Grant proceeds receivable	14,630	168,302
Other assets	3,647	6,349
Total current assets	183,323	210,565
Property and equipment, net of depreciation	61,820	76,916
Patents, net
Deferred debt issuance costs, net of amortization of $39,066 and $8,674 in 2011 and 2010	141,378	46,764
Deposits	3,350	3,350
Total Assets	389,871	337,595
Current Liabilities
Accounts payable and accrued expenses	492,532	218,639
Due to officers	32,359	22,709
Notes payable, less discount of $18,750 and $0 in 2011 and 2010	81,250
Total Current Liabilities	606,141	241,348
Long-term Liabilities
Notes payable, less discount of $672,497 and $659,564 in 2011 and 2010	377,503	90,436
Derivative liability	515,502	295,026
Total Long-term Liabilities	893,005	385,462
Total Liabilities	1,499,146	626,810
Commitments and Contingencies
Stockholders' deficit
Common stock - no par value, 750,000,000 shares authorized, 212,089,397 and 192,789,397 shares issued and outstanding at December 31, 2011 and 2010	518,585	112,405
Additional paid-in capital	1,628,234	725,745
Accumulated deficit during development stage	(3,256,094)	(1,127,365)
Total Stockholders' Deficit	(1,109,275)	(289,215)
Total Liabilities and Stockholders' Deficit	$ 389,871	$ 337,595